Search

everythinglearnresearchcommunity

for

Search:↓

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Male pattern baldness may be linked to prostate cancer risk.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Some skin medication can rarely cause or worsen mental health issues; knowing this is important because mental health problems are increasing worldwide.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The cause of post-finasteride syndrome is unclear and needs more research.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Finasteride and dutasteride do not significantly change beard thickness in men.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Non-prescription products can help manage androgenic alopecia.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Homeopathy can effectively treat pattern hair loss by using remedies like Lycopodium Clavatum and Natrum Muriaticum, tailored to the patient's overall condition.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.